Lotus Clinical Research
The specialty analgesic full-service contract research organization (CRO) announced new hires with the addition of Lee Simon, MD, FACP, FACR as principal advisor, osteoarthritis research, and Allan Green, MD, PhD, JD as medical imaging and research advisor.
Both will help support the design and conduct of Lotus' current osteoarthritis pain research programs and further expand the company’s osteoarthritis pain expertise and capabilities.
Simon has been a clinical Rheumatologist for 25 years and was previously the division director, analgesic, anti-inflammatory, ophthalmologic drug products (DAAODP), ODEV, CDER, at the US Food and Drug Administration (FDA).
He has served on consulting advisory boards for sponsors researching pain, anti-inflammatory effects, alteration of bone turnover, as well as modifying inflammatory disease states, and was previously a National Institutes of Health (NIH) funded investigator.
Simon also served on the Board of Directors of the American College of Rheumatology (ACR) and as the Chair of Education for the ACR and on the committee of the National Arthritis Foundation.
Green teaches food and drug law at Boston College Law School and has several US patents to his name, with more than 30 years of experience across the industry.
Previously, he was medical director of New England Nuclear/DuPont Medical Products, chief of nuclear medicine, University Hospitals, Boston, and an Instructor at Harvard Medical School. He is currently on the medical staff of Massachusetts General Hospital and Boston Medical Center.